ArticleChinese medical journal2019

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion.

Cun-Liang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.